<pmc-articleset xmlns:ns0="http://www.w3.org/1999/xlink">
<article xml:lang="en" article-type="research-article" dtd-version="1.4">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Nat Rev Cancer</journal-id>
<journal-id journal-id-type="iso-abbrev">Nat Rev Cancer</journal-id>
<journal-id journal-id-type="pmc-domain-id">319</journal-id>
<journal-id journal-id-type="pmc-domain">nihpa</journal-id>
<journal-title-group>
<journal-title>Nature reviews. Cancer</journal-title>
</journal-title-group>
<issn pub-type="ppub">1474-175X</issn>
<issn pub-type="epub">1474-1768</issn>
<custom-meta-group>
<custom-meta>
<meta-name>pmc-is-collection-domain</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-collection-title</meta-name>
<meta-value>NIHPA Author Manuscripts</meta-value>
</custom-meta>
</custom-meta-group>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmcid">PMC11924961</article-id>
<article-id pub-id-type="pmcid-ver">PMC11924961.1</article-id>
<article-id pub-id-type="pmcaid">11924961</article-id>
<article-id pub-id-type="pmcaiid">11924961</article-id>
<article-id pub-id-type="manuscript-id">NIHMS2061148</article-id>
<article-id pub-id-type="pmid">39511414</article-id>
<article-id pub-id-type="doi">10.1038/s41568-024-00768-6</article-id>
<article-id pub-id-type="manuscript-id-alternative">NIHMS2061148</article-id>
<article-id pub-id-type="manuscript-id-alternative">NIHPA2061148</article-id>
<article-version article-version-type="pmc-version">1</article-version>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Genetic and epigenetic bases of long-term adverse effects of childhood cancer therapy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name name-style="western">
<surname>Wang</surname>
<given-names initials="Z">Zhaoming</given-names>
</name>
<xref rid="A1" ref-type="aff">1</xref>
</contrib>
<contrib contrib-type="author">
<name name-style="western">
<surname>Zhang</surname>
<given-names initials="J">Jinghui</given-names>
</name>
<xref rid="A2" ref-type="aff">2</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Epidemiology and Cancer Control, St. Jude Children’s Research Hospital, Memphis, TN, USA.</aff>
<aff id="A2">
<label>2</label>Department of Computational Biology, St. Jude Children’s Research Hospital, Memphis, TN, USA.</aff>
<author-notes>
<fn fn-type="equal" id="FN1">
<p id="P1">The authors contributed equally to all aspects of the article.</p>
</fn>
<corresp id="CR1">
<bold>Corresponding authors</bold> Zhaoming Wang, <email>zhaoming.wang@stjude.org</email>, Jinghui Zhang, <email>jinghui.zhang@stjude.org</email>
</corresp>
<fn fn-type="COI-statement" id="FN2">
<p id="P43">Competing interests</p>
<p id="P44">The authors declare no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<month>2</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>07</day>
<month>11</month>
<year>2024</year>
</pub-date>
<volume>25</volume>
<issue>2</issue>
<issue-id pub-id-type="pmc-issue-id">484764</issue-id>
<fpage>129</fpage>
<lpage>144</lpage>
<pub-history>
<event event-type="nihms-submitted">
<date>
<day>13</day>
<month>03</month>
<year>2025</year>
</date>
</event>
<event event-type="pmc-release">
<date>
<day>01</day>
<month>08</month>
<year>2025</year>
</date>
</event>
<event event-type="pmc-live">
<date>
<day>01</day>
<month>08</month>
<year>2025</year>
</date>
</event>
<event event-type="pmc-released-under-embargo">
<date>
<day>21</day>
<month>03</month>
<year>2025</year>
</date>
</event>
<event event-type="pmc-last-change">
<date iso-8601-date="2025-08-01 00:25:14.163">
<day>01</day>
<month>08</month>
<year>2025</year>
</date>
</event>
</pub-history>
<self-uri content-type="pmc-pdf" ns0:href="nihms-2061148.pdf" />
<abstract id="ABS1">
<p id="P2">Over the past decade, genome-scale molecular profiling of large childhood cancer survivorship cohorts has led to unprecedented advances in our understanding of the genetic and epigenetic bases of therapy-related adverse health outcomes in this vulnerable population. To facilitate the integration of knowledge generated from these studies into formulating next-generation precision care for survivors of childhood cancer, we summarize key findings of genetic and epigenetic association studies of long-term therapy-related adverse effects including subsequent neoplasms and cardiomyopathies among others. We also discuss therapy-related genotoxicities including clonal haematopoiesis and DNA methylation, which may underlie accelerated molecular ageing. Finally, we highlight enhanced risk prediction models for survivors of childhood cancer that incorporate both genetic factors and treatment exposures, aiming to achieve enhanced accuracy in predicting risks for this population. These new insights will hopefully inspire future studies that harness both expanding omics resources and evolving data science methodology to accelerate the translation of precision medicine for survivors of childhood cancer.</p>
</abstract>
<custom-meta-group>
<custom-meta>
<meta-name>pmc-status-qastatus</meta-name>
<meta-value>0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-status-live</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-status-embargo</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-status-released</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-open-access</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-olf</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-manuscript</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-legally-suppressed</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-has-pdf</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-has-supplement</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-pdf-only</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-suppress-copyright</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-is-real-version</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-is-scanned-article</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-preprint</meta-name>
<meta-value>no</meta-value>
</custom-meta>
<custom-meta>
<meta-name>pmc-prop-in-epmc</meta-name>
<meta-value>yes</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
</article>
</pmc-articleset>